Multicentric osteolysis-nodulosis-arthropathy spectrum

What it is

From: Orphanet

A rare systemic or rheumatologic disease characterized by peripheral osteolysis (especially carpal and tarsal bones), interphalangeal joint erosions, subcutaneous fibrocollagenous nodules, facial dysmorphism, and a wide range of associated manifestations.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Abnormal facial shape · Very frequent (99-80%)

An abnormal morphology (form) of the face or its components.

Abnormal hand morphology · Very frequent (99-80%)

Any structural anomaly of the hand.

Arthritis · Very frequent (99-80%)

Inflammation of a joint.

Carpal osteolysis · Very frequent (99-80%)

Osteolysis affecting carpal bones.

Hirsutism · Very frequent (99-80%)

Abnormally increased hair growth referring to a male pattern of body hair (androgenic hair).

Osteolysis · Very frequent (99-80%)

Osteolysis refers to the destruction of bone through bone resorption with removal or loss of calcium.

Osteolysis involving tarsal bones · Very frequent (99-80%)

An increased resorption of bone matrix by osteoclasts leading to bony defects involving the tarsal bones.

Osteopenia · Very frequent (99-80%)

Osteopenia is a term to define bone density that is not normal but also not as low as osteoporosis. By definition from the World Health Organization osteopenia is defined by bone densitometry as a T score -1 to -2.5.

Osteoporosis · Very frequent (99-80%)

Osteoporosis is a systemic skeletal disease characterized by low bone density and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility. According to the WHO criteria, osteoporosis is defined as a BMD that lies 2.5 standard deviations or more below the average value for young healthy adults (a T-score below -2.5 SD).

Arthropathy · Very frequent (99-80%)

Osteolysis involving bones of the lower limbs · Very frequent (99-80%)

Osteolysis involving bones of the upper limbs · Very frequent (99-80%)

Abnormal form of the vertebral bodies · Frequent (79-30%)

Abnormal form of vertebral body, which is the central cylindrical portion of the vertebra that together with other structures such as the vertebral arch, pedicles, laminae, spinous process, transverse processes, and articular facets makes up a vertebra.

Abnormality of the cardiovascular system · Frequent (79-30%)

Any abnormality of the cardiovascular system.

Other findings in the same source

From: Orphanet

Additional reported features include Brachycephaly (Frequent (79-30%)); Broad clavicles (Frequent (79-30%)); Broad metacarpals (Frequent (79-30%)); Localized skin lesion (Frequent (79-30%)); Sclerotic cranial sutures (Frequent (79-30%)); Subcutaneous nodule (Frequent (79-30%)); Atrial septal defect (Occasional (29-5%)); Atrioventricular block (Occasional (29-5%)); Bicuspid aortic valve (Occasional (29-5%)); Coarctation of aorta (Occasional (29-5%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

Childhood; Infancy

Inheritance in the source

From: Orphanet

Autosomal recessive

Frequency and the population described

From: Orphanet

Reported case(s): 50.0; Worldwide. This is a published case count, not prevalence. Point prevalence: Unknown; Worldwide; Class only.

Understanding the inheritance label

From: MedlinePlus Genetics

An autosomal recessive pattern usually involves disease-causing changes in both copies of a gene. Parents may each carry one altered copy without having the condition themselves. A genetic counsellor can explain carrier testing and reproductive implications using the actual laboratory findings, rather than the condition name alone.

Which doctor should you see?

The suggested department for discussing Multicentric osteolysis-nodulosis-arthropathy spectrum is Rheumatology, with a rheumatologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

• Are the findings inflammatory, structural or due to another mechanism?
• Is there evidence that other organs need assessment?
• How will function and any treatment-related risks be monitored?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Multicentric osteolysis-nodulosis-arthropathy spectrum. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.